DC
PTCT icon

Deere & Company’s PTC Therapeutics PTCT Stock Holding History

Deere & Company’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-7,601
Closed -$463K – 1084
2015
Q1 		$463K Sell
7,601
-2,811
-27% -$172K 0.02% 658
2014
Q4 		$539K Hold
10,412
– – 0.03% 576
2014
Q3 		$458K Buy
+10,412
New +$326K 0.03% 644

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return

Deere & Company's PTCT Position: Q2 2015 in Review

Deere & Company sold out of PTC Therapeutics (PTCT) in Q2 2015, closing a stake of 7,601 shares — an estimated $463K sold.

Deere & Company first reported a position in PTCT in Q3 2014 and held it in 3 quarters. The position peaked at $539K in Q4 2014. 155 funds tracked by Wall St. Rank hold PTCT as of Q2 2015.

  • Deere & Company reported no remaining PTC Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Deere & Company sold 7,601 PTC Therapeutics shares in Q2 2015, an estimated $463K.
  • Deere & Company first reported a position in PTC Therapeutics in Q3 2014 and held it in 3 quarters.
  • Deere & Company's PTC Therapeutics position peaked at $539K in Q4 2014.
  • 155 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2015.

Based on Deere & Company's 13F filing for Q2 2015, filed 13 Aug 2015.